Insmed Incorporated Revenue for the Trailing 12 Months (TTM) ending March 31, 2025: USD 381.03 M

Insmed Incorporated Revenue is USD 381.03 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 20.77% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Insmed Incorporated Revenue for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 315.49 M, a 22.54% change year over year.
  • Insmed Incorporated Revenue for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 257.46 M, a 27.87% change year over year.
  • Insmed Incorporated Revenue for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 201.35 M, a 20.02% change year over year.
  • Insmed Incorporated Revenue for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 167.77 M, a 10.79% change year over year.
Key Data
Date Revenue Revenue Gross Profit Operating Income